The MarketReader Minute
💊 VKTX Down Despite Positive Obesity Drug Data; GILD Hits 8.5-Year High Ahead of Earnings; MDGL Gains on Novo Nordisk Data Boost | Biotech Sector Insights
(IBB) has seen a decrease of 0.1% since Friday. In the previous week, from October 28 to November 1, the ETF recorded a gain of 0.90%, reaching a price of 142.78. Key contributors to this performance included GILD, ILMN, APLS, HALO, and MTD, each registering positive returns.